Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Loeffler

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Pathogens (Basel, Switzerland)|April 30, 2021
Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case SeriesJasmin Heidepriem, Christine Dahlke, Robin Kobbe, et al.
RSC Medicinal Chemistry|October 21, 2021
Identification of a Zika NS2B epitope as a biomarker for severe clinical phenotypesFelix F Loeffler, Isabelle F T Viana, Nico Fischer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2010
Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activityLakshman E Rajagopalan, Michael S Davies, Larry E Kahn, et al.
Nature Communications|June 15, 2016
High-flexibility combinatorial peptide synthesis with laser-based transfer of monomers in solid matrix materialFelix F Loeffler, Tobias C Foertsch, Roman Popov, et al.
Nature Communications|July 19, 2022
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndromeAnahita Fathi, Christine Dahlke, Verena Krähling, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Pathogens (Basel, Switzerland)|April 30, 2021
Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case SeriesJasmin Heidepriem, Christine Dahlke, Robin Kobbe, et al.
RSC Medicinal Chemistry|October 21, 2021
Identification of a Zika NS2B epitope as a biomarker for severe clinical phenotypesFelix F Loeffler, Isabelle F T Viana, Nico Fischer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2010
Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activityLakshman E Rajagopalan, Michael S Davies, Larry E Kahn, et al.
Nature Communications|June 15, 2016
High-flexibility combinatorial peptide synthesis with laser-based transfer of monomers in solid matrix materialFelix F Loeffler, Tobias C Foertsch, Roman Popov, et al.
Nature Communications|July 19, 2022
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndromeAnahita Fathi, Christine Dahlke, Verena Krähling, et al.
Pageof 6